TUSC2 and non-small cell lung carcinoma: To further evaluate the biological activity of TUSC2-MK2206 combined treatment in the three tested LKB1-defective NSCLC cell lines, we measured induction of apoptosis using cell cycle analysis with fluorescence-activated cell sorting (FACS).